[1] YANG S E,ZHAO B.Research progress in the use of drugs for breast cancer targeted therapy[J].Chin J Clin Oncol,2008,5(3):320-325.
[2] PASKO J L,GARREAU J,CARL A,et al.Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer[J].Am J Surg,2015,209(5):890-895.
[3] CHANISHVILI N.Bacteriophages as the rapeutic and prophylactic means:summary of the soviet and post soviet experiences[J].Curr Drug Deliv,2016,13(3):309-323.
[4] 周彦君,曹旭晨,陆肖玮.局部晚期乳腺癌患者腋下逆行淋巴造影的可行性及肿瘤学安全性研究[J].中华肿瘤防治杂志,2015(b22):92-93.
[5] 贾苗苗,梁至洁,陈钦.降低乳腺癌术后淋巴水肿新技术——腋窝反向淋巴制图的研究进展[J].中国肿瘤临床,2014,41(3):211-214.
[6] LUITEN E J,BEEK M A,RUBIO I T.Clinical utility of axillary reverse mapping(ARM) in an era of changing perceptions concerning axillary surgery[J].Eur J Surg Oncol,2016,42(5):585-592.
[7] 喻大军,钱军,李靖,等.染料法腋窝反向淋巴作图300例临床研究[J].中国肿瘤临床,2013,40(21):1296-1299.
[8] FAN L,STRASSER-WEIPPL K,LI J J,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):279-289.
[9] VANDER VORST J R,SCHAAFSMA B E,VERBEEK F P,et al.Randomized comparison of near-infrared fluorescrence imaging using indocyanine green and99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients[J].Ann Surg Oncol,2012,19(13):4104-4111.
[10] von MINCKWITZ G,EIDTMANN H,REZAI M,et al.Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer[J].N Engl J Med,2012,366(5):299-309.
[11] BEEK M A,GOBARDHAN P D,SCHOENMAECKERS E J,et al.Axillary reverse mapping in axillary surgery for breast cancer:an update of the current status[J].Breast Cancer Res Treat,2016,158(3):421-453.
[12] GEBRUERS N,TJALMA W A.Clinical feasibility of axillary reverse mapping and its influence on breast cancer related lymphedema:a systematic review[J].Eur J Obstet Gynecol Reprod Biol,2016,200(3):117-139. |